1-14 of 14
Magaret Macro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Relative mortality in elderly frail patients with newly diagnosed multiple myeloma: Ad-hoc analysis of the Phase 3 IFM 2017-03 trial compared to population-based data in France and implications for the functional cure concept

Free
Julie Castiaux, Noemie Bigot, Cyrille Hulin, Magaret Macro, Kamel Laribi, Carla Araujo, Gian Matteo Pica, Cyrille Touzeau, Pascal Godmer, Aurore Perrot, Jean-Yves Mary, Jill Corre, Herve Avet-Loiseau, Philippe Moreau, Xavier Leleu, Thierry Facon, Jerome Lambert, Salomon Manier
Journal: Blood
Blood (2025) 146 (Supplement 1): 498.
https://doi.org/10.1182/blood-2025-498
Published: 2025
Journal Articles

Longitudinal assessments of minimal residual disease in high-risk patients from benefit phase 3 randomized Study of isatuximab plus lenalidomide and dexamethasone with bortezomib (Isa-VRd) versus isard in newly diagnosed transplant ineligible multiple myeloma. (IFM 2020-05)

Free
Anais Schavgoulidze, Jerome Lambert, Arthur Bobin, Salomon Manier, Aurore Perrot, Lionel Karlin, Murielle Roussel, Noemie Bigot, Omar Benbrahim, Olivier Allangba, Philippe Rey, Veronique Dorvaux, Marguerite Vignon, Virginie Roland, Reda Garidi, Jean-Noel Bastie, Marie-Lorraine Chrétien, Sophie Godet, Lydia Montes, Cherel Brieuc, Ikhlef Souhila, Anne Vekkhof, Thomas Chalopin, Bohrane Slama, Laurent Frenzel, Emilie Chalayer, Helene Gardeney, Magaret Macro, Bruno Royer, Stephanie Harel, Olivier Decaux, Bertrand Arnulf, Karim Belhadj Merzoug, Cyrille Touzeau, Mohamad Mohty, Aurelie Gontier, Philippe Moreau, Thierry Facon, Jill Corre, Cyrille Hulin, Xavier Leleu
Journal: Blood
Blood (2025) 146 (Supplement 1): 497.
https://doi.org/10.1182/blood-2025-497
Published: 2025
Journal Articles

First results of the rwe prospective study TEC care (IFM 2023-01) evaluating teclistamab in triple-class exposed relapsed refractory multiple myeloma patients.

Free
Aurore Perrot, Cyrille Hulin, Stephanie Harel, Veronique Vitry, Andrea Pieragostini, Salomon Manier, Carolyne Croizier, Pascal Lenain, Julie Gay, Laurent Frenzel, Thomas Chalopin, Emilie Chalayer, Edmond Chiche, Laure Vincent, Stephane Moreau, Magaret Macro, Lydia Montes, Driss Chaoui, Hélène Demarquette, Jean Marc Schiano De Colella, Cecile Sonntag Mottier, Frederique Orsini Piocelle, Veronique Dorvaux, Karim Belhadj Merzoug, Virginie Roland, Jean Fontan, Olivier Decaux, Cherel Brieuc, Riad Benramdane, Claire Breal, Dony Arthur, Sophie Vernet, Marie Pierres, Marie Odile Petillon, Philippe Moreau, Ariane Boumendil, Cyrille Touzeau
Journal: Blood
Blood (2025) 146 (Supplement 1): 5836.
https://doi.org/10.1182/blood-2025-5836
Published: 2025
Journal Articles

Apixaban pharmacokinetics in newly diagnosed multiple myeloma patients treated in the benefit and isasocut clinical trials: The apixabor/mibapix study

Free
Emilie Chalayer, Elisabeth Daguenet, Arthur Bobin, Thomas Fatrara, Ilhame Bounouara, Stephanie Noel, Karine Garnier, Lionel Karlin, Cyrille Touzeau, Olivier Decaux, Cyrille Hulin, Thomas Chalopin, Magaret Macro, Mamoun Dib, Mourad Tiab, Claire Dingremont, Pascal Godmer, Lydia Montes, Valérie Vidal, Adrienne Labarthe, Emmanuel Fleck, Laure Vincent, Jean-Sébastien Blade, Agathe Waultier-Rascalou, Julie Gay, Murielle Roussel, Frederique Orsini Piocelle, Laurent Frenzel, Philippe Moreau, Salomon Manier, Aurore Perrot, Xavier Leleu, Xavier Delavenne
Journal: Blood
Blood (2025) 146 (Supplement 1): 744.
https://doi.org/10.1182/blood-2025-744
Published: 2025
Journal Articles

Multicenter phase 2 study of subcutaneous isatuximab plus bortezomib , lenalidomide and dexamethasone (Isa Sc-VRd) in transplant ineligible newly diagnosed multiple myeloma: Final analysis of the isasocut study (IFM 2022-05)

Free
Arthur Bobin, Rick Zhang, Mony Morisse, Anais Schavgoulidze, Stéphanie Ragot, Christophe Roul, Thomas Chalopin, Lydia Montes, Mamoun Dib, Mourad Tiab, Frederique Orsini Piocelle, Thorsten Braun, Julie Gay, Carla Araujo, Reza Tabrizi, Laure Vincent, Alberto Santagostino, karine Garnier, Douaa Dhahri, Mohamad Mohty, Magaret Macro, Murielle Roussel, Lionel Karlin, Philippe Moreau, Cyrille Touzeau, Aurore Perrot, Thierry Facon, Cyrille Hulin, Jill Corre, Salomon Manier, Xavier Leleu
Journal: Blood
Blood (2025) 146 (Supplement 1): 2275.
https://doi.org/10.1182/blood-2025-2275
Published: 2025
Journal Articles

Sustained minimal residual disease (sMRD) negativity in transplant ineligible newly diagnosed multiple myeloma treated with isatuximab plus lenalidomide and dexamethasone with bortezomib (Isa-VRd) versus isa-rd: 12-24-month data from the phase 3 benefit trial (IFM 2020-05)

Free
Arthur Bobin, Jerome Lambert, Jill Corre, Salomon Manier, Aurore Perrot, Lionel Karlin, Murielle Roussel, Noemie Bigot, Kamel Laribi, Claire Dingremont, Christophe Roul, Valentine Richez, Clara Mariette, Sophie Rigaudeau, Claire Calmettes, Mamoun Dib, Mourad Tiab, Laure Vincent, Jacques Delaunay, Jean Pierre Marolleau, Pascal Godmer, Anaïs Schavgoulidze, Laurent Frenzel, Ronan Le Calloch, Emilie Chalayer, Helene Gardeney, Magaret Macro, Bruno Royer, Stephanie Harel, Olivier Decaux, Bertrand Arnulf, Karim Belhadj Merzoug, Cyrille Touzeau, Mohamad Mohty, Philippe Moreau, Thierry Facon, Cyrille Hulin, Xavier Leleu
Journal: Blood
Blood (2025) 146 (Supplement 1): 368.
https://doi.org/10.1182/blood-2025-368
Published: 2025
Journal Articles

A phase 2 Study of teclistamab in combination with daratumumab in elderly patients with newly diagnosed multiple myeloma: The IFM2021-01 teclille trial, cohort a

Free
Salomon Manier, Jerome Lambert, Magaret Macro, Thomas Chalopin, Mamoun Dib, Anne Rumpler, Julie Gay, Jean-Noel Bastie, Caroline Jacquet, Cecile Sonntag Mottier, Laure Vincent, Aurore Perrot, Clara Mariette, Lydia Montes, Sophie Rigaudeau, Noemie Bigot, Margaret Doyle, Diptendu Santra, Pavel Smirnov, Claire Albrecht, Cyrille Touzeau, Jill Corre, Philippe Moreau, Herve Avet-Loiseau, Cyrille Hulin, Xavier Leleu, Thierry Facon
Journal: Blood
Blood (2025) 146 (Supplement 1): 367.
https://doi.org/10.1182/blood-2025-367
Published: 2025
Journal Articles

The IFM2017-03 Phase 3 Trial: A Dexamethasone Sparing-Regimen with Daratumumab and Lenalidomide for Frail Patients with Newly-Diagnosed Multiple Myeloma

Free
Salomon Manier, Jérome Lambert, Cyrille Hulin, Kamel Laribi, Carla Araujo, Gian Matteo Pica, Cyrille Touzeau, Pascal Godmer, Bohrane Slama, Lionel Karlin, Frederique Orsini Piocelle, Mamoun Dib, Magaret Macro, Laurence Sanhes, Lydia Montes, Abderrazak El Yamani, Mourad Tiab, Reza Tabrizi, Laurent Garderet, Bruno Royer, Benoit Bareau, Aurore Perrot, Jean Yves Mary, Jill Corre, Herve Avet Loiseau, Philippe Moreau, Xavier Leleu, Thierry Facon
Journal: Blood
Blood (2024) 144 (Supplement 1): 774.
https://doi.org/10.1182/blood-2024-203045
Published: 2024
Journal Articles

Ixazomib and Daratumumab without Dexamethasone (I-Dara) in Elderly Frail RRMM Patients. a Multicenter Phase 2 Study (IFM 2018-02) of the Intergroupe Francophone Du Myélome (IFM)

Free
Magaret Macro, Cyrille Touzeau, Clara Mariette, Salomon Manier, Sabine Brechignac, Laure Vincent, Benjamin Hebraud, Olivier Decaux, Samantha Schulmann, Caroline Bureau Lenoir, Pascal Godmer, Jean-Jacques Parienti, Xavier Leleu
Journal: Blood
Blood (2021) 138 (Supplement 1): 83.
https://doi.org/10.1182/blood-2021-148152
Published: 2021
Journal Articles

In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present from the Diagnosis in Tiny Undetectable Subclones

Free
Herve Avet-Loiseau, Romain Lannes, Aurore Perrot, Céline Mazzotti, Marion Divoux, Titouan Cazaubiel, Xavier Leleu, Anaïs Schavgoulidze, Marie-Lorraine Chretien, Salomon Manier, Didier Adiko, Frédérique Orsini-Piocelle, Francois Lifermann, Sabine Brechignac, Lauris Gastaud, Didier Bouscary, Magaret Macro, Mohamad Mohty, Nikhil C. Munshi, Jill Corre
Journal: Blood
Blood (2021) 138 (Supplement 1): 77.
https://doi.org/10.1182/blood-2021-146869
Published: 2021
Journal Articles

The INSURE Study (INSIGHT MM, UVEA-IXA, REMIX): A Pooled Analysis of Relapsed/Refractory Multiple Myeloma (RRMM) Patients (pts) Treated with Ixazomib-Lenalidomide-Dexamethasone (IRd) in Routine Clinical Practice

Free
Xavier Leleu, Mario Boccadoro, Hans C. Lee, Jeffrey A. Zonder, Magaret Macro, Karthik Ramasamy, Cyrille Hulin, Jiri Silar, Matyáš Kuhn, Kaili Ren, Nawal Bent-Ennakhil, Sylvie Bouillie, Dasha Cherepanov, Dawn Marie Stull, Evangelos Terpos
Journal: Blood
Blood (2021) 138 (Supplement 1): 2701.
https://doi.org/10.1182/blood-2021-150150
Published: 2021
Journal Articles

Daratumumab Plus Ixazomib, Lenalidomide, and Dexamethasone As Extended Induction and Consolidation Followed By Lenalidomide Maintenance in Standard-Risk Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (IFM 2018-01): A Phase II Study of the Intergroupe Francophone Du Myélome (IFM)

Free
Aurore Perrot, Valérie Lauwers-Cances, Cyrille Touzeau, Olivier Decaux, Cyrille Hulin, Magaret Macro, Anne-Marie Stoppa, Marie Lorraine Chretien, Lionel Karlin, Clara Mariette, Caroline Jacquet, Murielle Roussel, Coralie Guillemot, Laure Devlamynck, Hervé Avet-Loiseau, Philippe Moreau, Michel Attal
Journal: Blood
Blood (2021) 138 (Supplement 1): 464.
https://doi.org/10.1182/blood-2021-146040
Published: 2021
Journal Articles

Meaningful Changes in Patient-Reported Outcomes in Relation to Best Clinical Response and Disease Progression: Post Hoc Analyses from MAIA

Free
Aurore Perrot, Thierry Facon, Shaji Kumar, Torben Plesner, Robert Z. Orlowski, Philippe Moreau, Nizar J. Bahlis, Supratik Basu, Hareth Nahi, Cyrille Hulin, Hang Quach, Hartmut Goldschmidt, Michael E. O'Dwyer, Chris P. Venner, Katja Weisel, Joseph R. Mace, Noopur S. Raje, Mourad Tiab, Magaret Macro, Laurent Frenzel, Xavier Leleu, Kevin Liu, John Fastenau, Katharine S. Gries, Kai Fai Ho, Pankaj Mistry, Brenda Tromp, Maria Delioukina, Jessica Vermeulen, Saad Z. Usmani
Journal: Blood
Blood (2021) 138 (Supplement 1): 4095.
https://doi.org/10.1182/blood-2021-150369
Published: 2021
Journal Articles

Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone: Update of the Phase 3 MAIA Trial

Free
Aurore Perrot, Thierry Facon, Shaji Kumar, Torben Plesner, Robert Z. Orlowski, Philippe Moreau, Nizar J. Bahlis, Supratik Basu, Hareth Nahi, Cyrille Hulin, Hang Quach, Hartmut Goldschmidt, Michael E. O'Dwyer, Chris P. Venner, Katja Weisel, Joseph R. Mace, Noopur S. Raje, Mourad Tiab, Magaret Macro, Laurent Frenzel, Xavier Leleu, Kevin Liu, John Fastenau, Katharine S. Gries, Kai Fai Ho, Pankaj Mistry, Brenda Tromp, Maria Delioukina, Jessica Vermeulen, Saad Z. Usmani
Journal: Blood
Blood (2021) 138 (Supplement 1): 1655.
https://doi.org/10.1182/blood-2021-144421
Published: 2021